Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis
- 1 April 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 55 (4) , 1470-1475
- https://doi.org/10.1046/j.1523-1755.1999.00378.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Prospective Study of Hyperhomocysteinemia as an Adverse Cardiovascular Risk Factor in End-Stage Renal DiseaseCirculation, 1998
- Hyperhomocysteinemia: detection, risk assessment, and treatmentCurrent Opinion in Nephrology and Hypertension, 1997
- Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomesKidney International, 1997
- Hyperhomocysteinemia Confers an Independent Increased Risk of Atherosclerosis in End-Stage Renal Disease and Is Closely Linked to Plasma Folate and Pyridoxine ConcentrationsCirculation, 1996
- Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patientsAtherosclerosis, 1996
- High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patientsKidney International, 1996
- Net uptake of plasma homocysteine by the rat kidney in vivoAtherosclerosis, 1995
- Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control studyAtherosclerosis, 1995
- Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: Possible implications for prevention of vascular diseaseMetabolism, 1988
- Aspects of Folate Metabolism in Renal FailureBritish Journal of Haematology, 1977